We can't find the internet
Attempting to reconnect
18546.1 PFLS-LS
18546.1 PFLS-LS
Zusammenfassung
Profiling of new oxytocin receptor agonists for the treatment of anxiety and autism spectrum disorders through a new microdrive-mounted optrode allowing combined electrophysiological and fMRI analyses.
Weitere Texte
Abstract
To profile newly developed oxytocin receptor agonists for anxiety and autism spectrum disorders by comparing their actions with those of endogenous oxytocin signaling in relevant brain circuits, we will construct and implement a fMRI compatible microdrive-mounted optrode that allows measurements of effects of optogenetically stimulated release of endogenous oxytocin using simultaneous fMRI scannings and electrophysiological recordings of single unit neuronal activity.
Beteiligte
Thomas Mueggler
Wirtschaftspartner
thomas.mueggler@roche.com
F. Hoffmann-La Roche Ltd Thomas Mueggler Building 73 / Grenzacherstrasse 124 4070 Basel BS CH
Ron Stoop
Kontaktperson
Ron.Stoop@unil.ch
CHUV Centre Hospitalier Universitaire Va Centre for Psychiatric Neuroscience Ron Stoop Hôpital de Cery / Route de Cery 1005 Lausanne VD CH
Projektdetails
- Forschungsstelle
- INNOSUISSE
- Projektstatus
- Abgeschlossen
- Projekttyp
- Forschungsprojekt
- Startdatum
- 2015-12-31
- Enddatum
- 2018-12-31
- Bewilligte Gesamtkosten
- CHF 558114.00
- Sektion
- 20 Förderbereich Life Sciences
- NABS Politikbereich
- Industrielle Produktivität und Technologie
Forschungsdisziplinen
- T115 Medical technology 100.0%